Literature DB >> 3029323

Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains.

C E Stokes, J N Hawthorne.   

Abstract

Samples of brain anterior temporal cortex from 17 patients with Alzheimer's disease and 18 age-matched controls have been analysed for myo-inositol and the three phosphoinositides. There was significantly less phosphatidylinositol in the Alzheimer samples (1.36 mumol/g wet weight) than in the controls (2.28 mumol/g). The concentrations of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate were also lower in Alzheimer cortex, but differences from the control group were not statistically significant. Free myo-inositol concentrations were 5.11 mumol/g (Alzheimer) and 4.44 mumol/g (control) and again the difference was not significant. The lack of phosphoinositides in Alzheimer temporal cortex may impair receptor function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029323     DOI: 10.1111/j.1471-4159.1987.tb05619.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  55 in total

Review 1.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.

Authors:  S Kaja; R S Duncan; S Longoria; J D Hilgenberg; A J Payne; N M Desai; R A Parikh; S L Burroughs; E V Gregg; D L Goad; P Koulen
Journal:  Neuroscience       Date:  2010-11-11       Impact factor: 3.590

3.  Dual-mode phospholipid regulation of human inward rectifying potassium channels.

Authors:  Wayland W L Cheng; Nazzareno D'Avanzo; Declan A Doyle; Colin G Nichols
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

4.  Measuring brain uptake and incorporation into brain phosphatidylinositol of plasma myo-[2H6]inositol in unanesthetized rats: an approach to estimate in vivo brain phosphatidylinositol turnover.

Authors:  Kaizong Ma; Joseph Deutsch; Nelly E Villacreses; Thad A Rosenberger; Stanley I Rapoport; H Umesha Shetty
Journal:  Neurochem Res       Date:  2006-06-22       Impact factor: 3.996

5.  Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.

Authors:  H U Shetty; R J Siarey; Z Galdzicki; J Stoll; S I Rapoport
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 6.  Lipidomics in translational research and the clinical significance of lipid-based biomarkers.

Authors:  Daniel J Stephenson; L Alexis Hoeferlin; Charles E Chalfant
Journal:  Transl Res       Date:  2017-06-15       Impact factor: 7.012

Review 7.  Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.

Authors:  A A Farooqui; L Liss; L A Horrocks
Journal:  Metab Brain Dis       Date:  1988-03       Impact factor: 3.584

8.  Phosphatidylinositol (4,5)-bisphosphate regulation of N-methyl-D-aspartate receptor channels in cortical neurons.

Authors:  Madhuchhanda Mandal; Zhen Yan
Journal:  Mol Pharmacol       Date:  2009-09-21       Impact factor: 4.436

Review 9.  Control of intracellular calcium signaling as a neuroprotective strategy.

Authors:  R Scott Duncan; Daryl L Goad; Michael A Grillo; Simon Kaja; Andrew J Payne; Peter Koulen
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

10.  Genome-wide identification of new Wnt/beta-catenin target genes in the human genome using CART method.

Authors:  Christian Hödar; Rodrigo Assar; Marcela Colombres; Andrés Aravena; Leonardo Pavez; Mauricio González; Servet Martínez; Nibaldo C Inestrosa; Alejandro Maass
Journal:  BMC Genomics       Date:  2010-06-01       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.